Skip to main content
Logo: EPEMED, The European Personalised Medicine Association
EPEMED
  • Home
  • Context
  • Role
  • Call to action
  • E-Learning
  • Knowledge Ctr
  • Newsletter
  • Members
  • Contact
  • Introduction & Login
  • Clinical & Research Centers
  • Industry Reports
  • Educational programs
  • Regulatory & Reimbursement
  • Deals & Partnerships in PM
    • Mergers & acquisitions
    • Pharma partnering
    • Values & trends prior 2015
  • Other Organisations
  • Leave your feedback

Mergers & acquisitions in PM space

Diaceutics analysed reports of M&A deals that have been publicly disclosed via press releases and news outlets. The wide variety of players involved included Big Pharma, biotech, in vitro diagnostics or medical devices manufacturers, information technology companies and laboratory services providers.

1. Number of the M&A deals in the PM space, publicly reported worldwide in the first two quarters of 2015.
2. Regional distribution of the publicly reported M&A deals in the PM space in the first two quarters of 2015.
3. Number of publicly reported M&A deals in the PM space in the first two quarters of 2015 per region.
4. Global value of the publicly reported M&A deals in the PM space in the first two quarters of 2015.
5. Value of the publicly reported M&A deals in the PM space in the first two quarters of 2015 per region.
  • Context
  • Role
  • Call to action
  • E-Learning
  • Knowledge Ctr
  • Newsletter
  • Members
  • Contact
  • 3 Programmatic Commitees…
  • Public Fora
  • News & Publications
  • International Events & Resources
  • Health Economic Policy and Reimbursement
  • Regulatory
  • Education
  • Our Annual Conference
  • Meet us across Europe
  • News
  • Studies & Reports
  • Articles
  • Others
  • Upcoming Events
  • Past Events
  • Library
EPEMED ASBL LUXEMBOURG
59, RUE DU 10 OCTOBRE
L-7243 BERELDANGE
contact@epemed.org